Dashboard
Manage Tickers

ATKRAtkore Inc.

NYSE atkore.com


$ 144.79 $ 1.63 (1.14 %)    

Monday, 15-Jul-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 496.90 $ 1.33 (0.27 %)
DIA $ 402.52 $ 2.04 (0.51 %)
SPY $ 561.53 $ 1.54 (0.28 %)
TLT $ 92.88 $ -1.08 (-1.15 %)
GLD $ 223.86 $ 0.72 (0.32 %)
$ 144.76
$ 143.59
$ 0.00 x 0
$ 0.00 x 0
$ 143.08 - $ 147.54
$ 120.49 - $ 194.57
446,934
na
5.27B
$ 1.79
$ 8.53
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-29-2024 10-Q
2 01-31-2024 12-29-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 02-01-2023 12-30-2022 10-Q
6 11-18-2022 09-30-2022 10-K
7 08-01-2022 06-24-2022 10-Q
8 05-02-2022 03-25-2022 10-Q
9 01-28-2022 12-24-2021 10-Q
10 11-17-2021 09-30-2021 10-K
11 08-03-2021 06-25-2021 10-Q
12 04-29-2021 03-26-2021 10-Q
13 02-02-2021 12-25-2020 10-Q
14 11-19-2020 09-30-2020 10-K
15 08-04-2020 06-26-2020 10-Q
16 05-05-2020 03-27-2020 10-Q
17 02-04-2020 12-27-2019 10-Q
18 11-22-2019 09-30-2019 10-K
19 08-07-2019 06-28-2019 10-Q
20 05-07-2019 03-29-2019 10-Q
21 02-06-2019 12-28-2018 10-Q
22 11-28-2018 09-30-2018 10-K
23 08-07-2018 06-29-2018 10-Q
24 05-08-2018 03-30-2018 10-Q
25 02-06-2018 12-29-2017 10-Q
26 11-29-2017 09-30-2017 10-K
27 08-08-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 02-07-2017 12-30-2016 10-Q
30 11-29-2016 09-30-2016 10-K
31 08-02-2016 06-24-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

atkore-is-a-highly-compelling-electrification-opportunity-says-bullish-analyst
Atkore Is A 'Highly Compelling' Electrific...
07/10/2024 14:30:56

Atkore is currently trading at a significant discount to peers, despite the company's strong growth and returns.

keybanc-initiates-coverage-on-atkore-with-overweight-rating-announces-price-target-of-175
Keybanc Initiates Coverage On Atkore with ...
07/10/2024 09:51:48

Keybanc analyst Jeffrey Hammond initiates coverage on Atkore (NYSE:ATKR) with a Overweight rating and announces Price Target...

top-3-industrials-stocks-that-may-rocket-higher-in-q2
Top 3 Industrials Stocks That May Rocket H...
06/24/2024 12:21:41

looking-into-atkores-recent-short-interest
Looking Into Atkore's Recent Short Interest
05/30/2024 13:30:16

citigroup-maintains-neutral-on-atkore-lowers-price-target-to-188
Citigroup Maintains Neutral on Atkore, Low...
05/08/2024 19:36:49

Citigroup analyst Andrew Kaplowitz maintains Atkore (NYSE:ATKR) with a Neutral and lowers the price target from $200 to $188.

atkore-2024-outlook-lowered-now-expects-adjusted-eps-of-1600-1700-prior-1650-1750-est-1693-sees-adjusted-ebitda-of-850m-to-900m
Atkore 2024 Outlook, Lowered: Now Expects ...
05/07/2024 10:06:38

Full-Year Outlook1 The Company is adjusting its estimate for fiscal year 2024 Adjusted EBITDA to be approximately $850 million...

atkore-q2-2024-adj-eps-408-beats-382-estimate-sales-792911m-miss-806331m-estimate
Atkore Q2 2024 Adj EPS $4.08 Beats $3.82 E...
05/07/2024 10:02:23

Atkore (NYSE:ATKR) reported quarterly earnings of $4.08 per share which beat the analyst consensus estimate of $3.82 by 6.81 pe...

citigroup-maintains-neutral-on-atkore-raises-price-target-to-200
Citigroup Maintains Neutral on Atkore, Rai...
04/08/2024 22:33:19

Citigroup analyst Andrew Kaplowitz maintains Atkore (NYSE:ATKR) with a Neutral and raises the price target from $176 to $200.

rbc-capital-reiterates-outperform-on-atkore-maintains-187-price-target
RBC Capital Reiterates Outperform on Atkor...
03/22/2024 15:00:15

RBC Capital analyst Deane Dray reiterates Atkore (NYSE:ATKR) with a Outperform and maintains $187 price target.

atkores-ex-dividend-date-is-monday-heres-what-you-need-to-know
Atkore's Ex-Dividend Date Is Monday, Here'...
02/21/2024 14:45:56

peering-into-atkores-recent-short-interest
Peering Into Atkore's Recent Short Interest
02/09/2024 13:30:13

rbc-capital-reiterates-outperform-on-atkore-maintains-187-price-target
RBC Capital Reiterates Outperform on Atkor...
02/02/2024 15:36:38

RBC Capital analyst Deane Dray reiterates Atkore (NYSE:ATKR) with a Outperform and maintains $187 price target.

atkore-raises-fy24-outlook-for-adjusted-eps-from-1600-1700-to-1650-1750-est-1671
Atkore Raises FY24 Outlook For Adjusted EP...
02/01/2024 11:05:07

atkore-q1-adj-eps-412-beats-361-estimate-sales-79848m-beat-77687m-estimate
Atkore Q1 Adj EPS $4.12 Beats $3.61 Estima...
02/01/2024 11:01:29

Atkore (NYSE:ATKR) reported quarterly Adj earnings of $4.12 per share which beat the analyst consensus estimate of $3.61 by 14....

earnings-scheduled-for-february-1-2024
Earnings Scheduled For February 1, 2024
02/01/2024 10:03:12

Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NY...

earnings-preview-for-atkore
Earnings Preview For Atkore
01/31/2024 20:01:01

5-value-stocks-in-the-industrials-sector
5 Value Stocks In The Industrials Sector
01/31/2024 14:41:26

atkore-inc-initiates-quarterly-dividend-of-032share
Atkore Inc. Initiates Quarterly Dividend O...
01/30/2024 21:45:06

overview-of-value-stocks-in-the-industrials-sector
Overview Of Value Stocks In The Industrial...
01/24/2024 14:41:10

this-tech-stock-is-too-expensive-cramer-says-wait-for-a-pullback
This Tech Stock Is 'Too Expensive,' Cramer...
12/08/2023 14:07:23

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Camtek Ltd.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)